Boston Scientific Corporation (LON:0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
105.18
-0.38 (-0.36%)
At close: Aug 1, 2025
-0.36%
Market Cap117.73B
Revenue (ttm)13.50B
Net Income (ttm)1.83B
Shares Outn/a
EPS (ttm)1.23
PE Ratio64.39
Forward PE33.55
Dividendn/a
Ex-Dividend Daten/a
Volume2,485
Average Volume4,778
Open103.00
Previous Close105.56
Day's Range103.00 - 106.14
52-Week Range71.88 - 109.09
Beta0.68
RSI51.94
Earnings DateJul 23, 2025

About United States Steel

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 53,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial Statements

News

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

All but two of the S&P 500's sectors are up so far in 2025.

1 day ago - Market Watch

This health care stock forming a 'big base breakout' is ready to separate from the pack, charts indicate

David Keller breaks down the charts in Boston Scientific.

8 days ago - CNBC

Cramer's Stop Trading: Boston Scientific

Jim Cramer breaks down why he's keeping an eye on shares of Boston Scientific.

9 days ago - CNBC Television

Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance

Stronger‑than‑expected sales and raised full‑year guidance underscore Boston Scientific Corporation ‘s (NYSE: BSX) momentum—and hint at where its next product wins may come. Boston Scientific on Wedn...

9 days ago - Benzinga

Cramer's Stop Trading: Boston Scientific

Jim Cramer breaks down why he's keeping an eye on shares of Boston Scientific.

9 days ago - CNBC

Boston Scientific Eyes Breakout On Strong Second Quarter, Guidance

Boston Scientific stock jumped early Wednesday on a strong second-quarter report and guidance for the full year.

9 days ago - Investor's Business Daily

Boston Scientific lifts annual profit view on steady heart devices demand

Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates.

9 days ago - Reuters

Boston Scientific announces results for second quarter 2025

MARLBOROUGH, Mass. , July 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.061 billion during the second quarter of 2025, growing 22.8 percent on a reported...

10 days ago - PRNewsWire

Earnings Scheduled For July 23, 2025

Companies Reporting Before The Bell • Equinor (NYSE: EQNR) is projected to report quarterly earnings at $0.26 per share on revenue of $24.67 billion. • Thermo Fisher Scientific (NYSE: TMO) is expect...

10 days ago - Benzinga

Boston Scientific Q2 2025 Earnings Preview

10 days ago - Seeking Alpha

How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?

Boston Scientific (NYSE:BSX) is set to announce its earnings on Wednesday, July 23, 2025. In the last five years, BSX stock has shown a positive return on the day after earnings announcements in 60% o...

10 days ago - Forbes

North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf

Explore the "North America Ureteroscopes Market Outlook to 2033" for key insights into the Ureteroscopes market. The report covers annualized market revenues, volume, and average prices across segment...

22 days ago - GlobeNewsWire

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass. , July 7, 2025 /PRNewswire/ -- Boston Scientific...

26 days ago - PRNewsWire

Boston Scientific announces conference call discussing second quarter 2025 results

MARLBOROUGH, Mass. , July 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter...

4 weeks ago - PRNewsWire

I'm Buying Dividend Aristocrats At Bargain Basement Prices

Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-cove...

6 weeks ago - Seeking Alpha

S&P 500 Surges 1%; New York Manufacturing Activity Tumbles In June

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 1% on Monday. The Dow traded up 0.80% to 42,536.72 while the NASDAQ climbed 1.51% to 19,699.21. The S&P 500 also rose,...

6 weeks ago - Benzinga

What's Happening With Boston Scientific Stock?

Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to th...

6 weeks ago - Forbes

US Stocks Higher; Dow Jumps Over 400 Points

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 400 points on Monday. Following the market opening Monday, the Dow traded up 1.02% to 42,629.20 while the NASDAQ clim...

6 weeks ago - Benzinga

This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...

6 weeks ago - Benzinga

$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 18.87%. Currently, Boston Scientific has a marke...

7 weeks ago - Benzinga

20 stocks bucking bad trends on Wall Street — what might be next for them?

Analysts have been cutting their estimates for companies' sales and profits, but there are always exceptions to trends.

7 weeks ago - Market Watch